• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环磷酰胺通过CXCR4和基质金属蛋白酶促进乳腺癌细胞迁移。

Cyclophosphamide promotes breast cancer cell migration through CXCR4 and matrix metalloproteinases.

作者信息

Hung Chao-Ming, Hsu Yi-Chiang, Chen Tzu-Yu, Chang Chi-Chang, Lee Mon-Juan

机构信息

Department of General Surgery, E-Da Hospital, I-Shou, University, Kaohsiung, Taiwan.

Graduate Institute of Medical Sciences, Chang Jung Christian University, Tainan, Taiwan.

出版信息

Cell Biol Int. 2017 Mar;41(3):345-352. doi: 10.1002/cbin.10726. Epub 2017 Jan 23.

DOI:10.1002/cbin.10726
PMID:28035725
Abstract

Cyclophosphamide is indicated for the treatment of cancerous diseases such as breast cancer and cervical cancer. Recent studies have shown that cyclophosphamide may induce cancer metastasis, but the cause of this unexpected adverse effect is not fully understood. In this study, we investigate the effect of cyclophosphamide on cancer cell migration and its correlation to chemokine (C-X-C motif) receptor 4 (CXCR4), a biomarker for cancer metastasis. Two human cancer cell lines with significant difference in endogenous CXCR4 expression, the breast cancer cell line, MDA-MB-231, and the melanoma cell line, MDA-MB-435S, were treated with various concentrations of cyclophosphamide, followed by the assessment of CXCR4 expression and cell migration. We found that the migration ability of MDA-MB-231 cells was enhanced with increasing concentrations of cyclophosphamide, which induced the cell-surface expression of CXCR4, but had no effect on the overall amount of CXCR4. In MDA-MB-435S cells, in which CXCR4 was barely detectable, cyclophosphamide was unable to activate cell-surface CXCR4, and did not promote cell migration. Studies on the mRNA expression profile of matrix metalloproteinases (MMPs) in MDA-MB-231 cells further indicate that MMP9 and MMP13 may be involved in the action of cyclophosphamide. The protein expression of both MMP9 and MMP13 was increased in the presence of cyclophosphamide. Results from this study provide the molecular basis for the possible pathway of cyclophosphamide to induce cancer metastasis.

摘要

环磷酰胺适用于治疗诸如乳腺癌和宫颈癌等癌症疾病。最近的研究表明,环磷酰胺可能会诱导癌症转移,但其这种意外副作用的原因尚未完全了解。在本研究中,我们调查了环磷酰胺对癌细胞迁移的影响及其与趋化因子(C-X-C基序)受体4(CXCR4)的相关性,CXCR4是一种癌症转移的生物标志物。用不同浓度的环磷酰胺处理内源性CXCR4表达存在显著差异的两个人类癌细胞系,即乳腺癌细胞系MDA-MB-231和黑色素瘤细胞系MDA-MB-435S,随后评估CXCR4表达和细胞迁移情况。我们发现,随着环磷酰胺浓度的增加,MDA-MB-231细胞的迁移能力增强,环磷酰胺诱导了CXCR4的细胞表面表达,但对CXCR4的总量没有影响。在几乎检测不到CXCR4的MDA-MB-435S细胞中,环磷酰胺无法激活细胞表面的CXCR4,也不促进细胞迁移。对MDA-MB-231细胞中基质金属蛋白酶(MMPs)的mRNA表达谱的研究进一步表明,MMP9和MMP13可能参与了环磷酰胺的作用。在存在环磷酰胺的情况下,MMP9和MMP13的蛋白表达均增加。本研究结果为环磷酰胺诱导癌症转移的可能途径提供了分子基础。

相似文献

1
Cyclophosphamide promotes breast cancer cell migration through CXCR4 and matrix metalloproteinases.环磷酰胺通过CXCR4和基质金属蛋白酶促进乳腺癌细胞迁移。
Cell Biol Int. 2017 Mar;41(3):345-352. doi: 10.1002/cbin.10726. Epub 2017 Jan 23.
2
Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.对基质细胞衍生因子-1进行基因操作证明了自分泌SDF-1-CXCR4通路在乳腺癌细胞侵袭性中的关键作用。
Int J Oncol. 2005 May;26(5):1429-34.
3
Transendothelial migration of two metastatic breast carcinoma cells depend on the SDF-lalpha-CXCR4 complexes.两种转移性乳腺癌细胞的跨内皮迁移依赖于基质细胞衍生因子-1α-趋化因子受体4复合物。
Anticancer Res. 2004 Nov-Dec;24(6):4011-7.
4
Omega-3 polyunsaturated fatty acids down-modulate CXCR4 expression and function in MDA-MB-231 breast cancer cells.ω-3多不饱和脂肪酸下调MDA-MB-231乳腺癌细胞中CXCR4的表达及功能。
Mol Cancer Res. 2009 Jul;7(7):1013-20. doi: 10.1158/1541-7786.MCR-08-0385. Epub 2009 Jun 30.
5
Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.双功能融合多肽抑制乳腺癌的生长和转移。
Drug Des Devel Ther. 2015 Oct 16;9:5671-86. doi: 10.2147/DDDT.S90082. eCollection 2015.
6
Norepinephrine attenuates CXCR4 expression and the corresponding invasion of MDA-MB-231 breast cancer cells via β2-adrenergic receptors.去甲肾上腺素通过β2-肾上腺素能受体减弱CXCR4表达及MDA-MB-231乳腺癌细胞的相应侵袭能力。
Eur Rev Med Pharmacol Sci. 2015 Apr;19(7):1170-81.
7
Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line.去甲氧基姜黄素抑制 MDA-MB-231 人乳腺癌细胞系的迁移和侵袭。
Eur J Pharmacol. 2010 Feb 10;627(1-3):8-15. doi: 10.1016/j.ejphar.2009.09.052. Epub 2009 Oct 7.
8
PEA3 activates CXCR4 transcription in MDA-MB-231 and MCF7 breast cancer cells.PEA3 激活 MDA-MB-231 和 MCF7 乳腺癌细胞中的 CXCR4 转录。
Acta Biochim Biophys Sin (Shanghai). 2011 Oct;43(10):771-8. doi: 10.1093/abbs/gmr070. Epub 2011 Aug 10.
9
[The effects of shRNA-CXCR4 on breast cancer cells migration and invasion].[shRNA-CXCR4对乳腺癌细胞迁移和侵袭的影响]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2009 May;40(3):393-7.
10
Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke.一氧化氮供体上调基质细胞衍生因子-1/趋化因子(CXC基序)受体4可增强骨髓基质细胞在中风后向缺血性脑内的迁移。
Stem Cells. 2007 Nov;25(11):2777-85. doi: 10.1634/stemcells.2007-0169. Epub 2007 Jul 19.

引用本文的文献

1
CXCR4/CXCL12 blockade therapy; a new horizon in TNBC therapy.CXCR4/CXCL12阻断疗法:三阴性乳腺癌治疗的新前沿。
Med Oncol. 2025 Apr 11;42(5):161. doi: 10.1007/s12032-025-02705-5.
2
Upregulation of C-X-C chemokine receptor type 4 (CXCR4) in the breast cancer stem like cells.乳腺癌干细胞样细胞中C-X-C趋化因子受体4(CXCR4)的上调。
Am J Stem Cells. 2023 Aug 15;12(3):60-64. eCollection 2023.
3
Therapeutic Implications of the Drug Resistance Conferred by Extracellular Vesicles Derived from Triple-Negative Breast Cancer Cells.
三阴性乳腺癌细胞衍生的细胞外囊泡赋予的耐药性的治疗意义
Int J Mol Sci. 2023 Feb 12;24(4):3704. doi: 10.3390/ijms24043704.
4
Downregulation of MMP-9 Enhances the Anti-Migratory Effect of Cyclophosphamide in MDA-MB-231 and MCF-7 Breast Cancer Cell Lines.下调 MMP-9 增强环磷酰胺对 MDA-MB-231 和 MCF-7 乳腺癌细胞系的抗迁移作用。
Int J Mol Sci. 2021 Nov 26;22(23):12783. doi: 10.3390/ijms222312783.
5
Branched-Chain Amino Acids Catabolism Pathway Regulation Plays a Critical Role in the Improvement of Leukopenia Induced by Cyclophosphamide in 4T1 Tumor-Bearing Mice Treated With Lvjiaobuxue Granule.支链氨基酸分解代谢途径调控在吕胶补血颗粒治疗的4T1荷瘤小鼠中对环磷酰胺诱导的白细胞减少症的改善起关键作用。
Front Pharmacol. 2021 Oct 25;12:657047. doi: 10.3389/fphar.2021.657047. eCollection 2021.
6
Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling.耐药性癌细胞衍生的外泌体 EphA2 通过 EphA2-Ephrin A1 反向信号促进乳腺癌转移。
Cell Death Dis. 2021 Apr 20;12(5):414. doi: 10.1038/s41419-021-03692-x.
7
The Recombinant Protein Based on P21 Interacts With CXCR4 Receptor and Abrogates the Invasive Phenotype of Human Breast Cancer Cells.基于P21的重组蛋白与CXCR4受体相互作用并消除人乳腺癌细胞的侵袭表型。
Front Cell Dev Biol. 2020 Oct 19;8:569729. doi: 10.3389/fcell.2020.569729. eCollection 2020.
8
Chemotherapy-Induced Upregulation of Small Extracellular Vesicle-Associated PTX3 Accelerates Breast Cancer Metastasis.化疗诱导的小细胞外囊泡相关 PTX3 的上调加速乳腺癌转移。
Cancer Res. 2021 Jan 15;81(2):452-463. doi: 10.1158/0008-5472.CAN-20-1976. Epub 2020 Oct 28.
9
Inhibition of chemotherapy-related breast tumor EMT by application of redox-sensitive siRNA delivery system CSO-ss-SA/siRNA along with doxorubicin treatment.通过应用氧化还原敏感的小干扰RNA递送系统CSO-ss-SA/siRNA并联合阿霉素治疗来抑制化疗相关的乳腺肿瘤上皮-间质转化
J Zhejiang Univ Sci B. 2020 Mar;21(3):218-233. doi: 10.1631/jzus.B1900468.
10
The progress of circular RNAs in various tumors.环状RNA在各种肿瘤中的研究进展。
Am J Transl Res. 2018 Jun 15;10(6):1571-1582. eCollection 2018.